Gregory Da Costa

Gregory Da Costa

Auto-generated profile, based on publicly available information

Gregory Da Costa

Micalis Institute, Université Paris-Saclay, INRAE, AgroParisTech, 78352 Jouy-en-Josas, France

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2016 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
BLBruno Lamas
Bruno Lamas
MRMathias L Richard
Mathias L Richard
VLValentin Leducq
Valentin Leducq
HPHang-Phuong Pham
Hang-Phuong Pham
MMMarie-Laure Michel
Marie-Laure Michel
HSHarry Sokol
Harry Sokol

1 November 2018 in Cell Metabolism
Verified
Journal Article
Closed access
JNJane M. Natividad
Jane M. Natividad
AAAllison Agus
Allison Agus
JPJulien Planchais
Julien Planchais
BLBruno Lamas
Bruno Lamas
AJAnne Charlotte Jarry
Anne Charlotte Jarry
HSHarry Sokol
Harry Sokol

18 July 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
JNJane M. Natividad
Jane M. Natividad
BLBruno Lamas
Bruno Lamas
HPHang Phuong Pham
Hang Phuong Pham
MMMarie-Laure Michel
Marie-Laure Michel
DRDominique Rainteau
Dominique Rainteau
HSHarry Sokol
Harry Sokol
Dietary lipids favor the growth of the pathobiont Bilophila wadsworthia, but the relevance of this expansion in metabolic syndrome pathogenesis is poorly understood. Here, we showed that B. wadsworthia synergizes with high fat diet (HFD) to promote higher inflammation, intestinal barrier dysfunction and bile acid dysmetabolism, leading to higher glucose dysmetabolism and hepatic steatosis. Host-microbiota transcriptomics analysis reveal pathways, particularly butanoate metabolism, which may underlie the metabolic effects mediated by B. wadsworthia. Pharmacological suppression of B. wadsworthia-associated inflammation demonstrate the bacterium’s intrinsic capacity to induce a negative impact on glycemic control and hepatic function. Administration of the probiotic Lactobacillus rhamnosus CNCM I-3690 limits B. wadsworthia-induced immune and metabolic impairment by limiting its expansion, reducing inflammation and reinforcing intestinal barrier. Our results suggest a new avenue for interventions against western diet-driven inflammatory and metabolic diseases.

15 November 2015 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
PDF file
GLGiuseppina Liguori
Giuseppina Liguori
BLBruno Lamas
Bruno Lamas
MRMathias L. Richard
Mathias L. Richard
GBGiovanni Brandi
Giovanni Brandi
GCGregory da Costa
Gregory da Costa
HSHarry Sokol
Harry Sokol
Background & Aims: Gut microbiota is involved in many physiological functions and its imbalance is associated with several diseases, particularly with inflammatory bowel diseases. Mucosa-associated microbiota could have a key role in induction of host immunity and in inflammatory process. Although the role of fungi has been suggested in inflammatory disease pathogenesis, the fungal microbiota has not yet been deeply explored. Here we analyzed the bacterial and fungal composition of the mucosa associated microbiota of Crohn’s disease patients and healthy subjects. Methods: Our prospective, observational study evaluated bacterial and fungal composition of mucosa-associated microbiota of 23 Crohn’s disease patients (16 in flare, 7 in remission) and 10 healthy subjects using 16S (MiSeq) and ITS2 (pyrosequencing) sequencing, respectively. Global fungal load was assessed by real time quantitative PCR. Results: Bacterial microbiota in Crohn’s disease patients was characterized by a restriction in biodiversity with an increase of Proteobacteria and Fusobacteria. Global fungi load was significantly increased in Crohn’s disease flare compared to healthy subjects (p < .05). In both groups, the colonic mucosa-associated fungal microbiota was dominated by Basidiomycota and Ascomycota phyla. Cystofilobasidiaceae family and Candida glabrata species were overrepresented in Crohn’s disease. Saccharomyces cerevisiae and Filobasidium uniguttulatum species were associated with non-inflamed mucosa whereas Xylariales order was associated with inflamed mucosa. Conclusions: Our study confirms the alteration of the bacterial microbiota and is the first demonstration of the existence of an altered fungal microbiota in Crohn’s disease patients suggesting that fungi may play a role in its pathogenesis.

1 October 2008 in Fungal Genetics and Biology
Verified
Journal Article
Open access
APArmêl Plaine
Armêl Plaine
LWLouise Walker
Louise Walker
GCGregory Da Costa
Gregory Da Costa
Héctor Mora-MontesHéctor Mora-Montes
Héctor Mora-Montes
AMAlastair McKinnon
Alastair McKinnon
MRMathias L. Richard
Mathias L. Richard
The outer layer of the Candida albicans cell wall is enriched in highly glycosylated proteins. The major class, the GlycosylPhosphatidylInositol (GPI)-anchored proteins are tethered to the wall by GPI-anchor remnants and include adhesins, glycosyltransferases, yapsins and superoxide dismutases. In silico analysis suggested that C. albicans possesses 115 putative GPI anchored proteins (GpiPs), almost twice the number reported for Saccharomyces cerevisiae. A global approach to characterise in silico predicted GpiPs has been initiated by generating a library of 45 mutants. This library was subjected to a screen for cell wall modifications by testing the cell wall integrity (SDS and Calcofluor White sensitivity) and response to caspofungin. We showed that, when caspofungin sensitivity was modified, in more than half of the cases the susceptibility can be correlated to the level of chitin and cell wall thickness: sensitive strains have low level of chitin and a thin cell wall. We also identified, for the first time, genes that when deleted lead to decreased caspofungin sensitivity: DFG5, PHR1, PGA4 and PGA62. The role of two unknown GpiPs, Pga31 and Pga62 in the cell wall structure and composition was clearly demonstrated during this study.

12 October 2017 in Gut Microbes
Verified
Journal Article
Closed access
MRMathias L. Richard
Mathias L. Richard
GLGiuseppina Liguori
Giuseppina Liguori
BLBruno Lamas
Bruno Lamas
GBGiovanni Brandi
Giovanni Brandi
GCGregory da Costa
Gregory da Costa
HSHarry Sokol
Harry Sokol
Gut microbiota dysbiosis has been associated with inflammatory bowel diseases (IBD). In colorectal cancer, the gut microbiota has also been recognized as potentially involved in aggravating or favoring the tumor development. However, very little is known on the structure and role of the microbiota in colitis associated cancer (CAC), an important complication of IBD in human. Here we analyzed the bacterial and fungal composition of the mucosa associated microbiota of patients suffering CAC, sporadic cancer (SC) and of healthy subjects (HS) by barcode sequences analysis on the following cohort: 7 CAC patients, 10 SC patients and 10 HS using 16S (MiSeq) and ITS2 (pyrosequencing) sequencing, for bacteria and fungi respectively. Mucosa-associated bacterial microbiota in CAC was significantly different from the ones in SC or in HS, while the fungal showed no differences. Comparison between mucosa-associated microbiota on the tumor site or in normal mucosa near the tumor showed very similar patterns. The global mucosa-associated bacterial microbiota in cancer patients was characterized by a restriction in biodiversity but no change for the fungal community. Compared to SC, CAC was characterized by an increase of Enterobacteriacae family and Sphingomonas genus and a decrease of Fusobacterium and Ruminococcus genus. Our study confirms the alteration of the mucosa-associated bacterial microbiota in IBD and SC. Although the cohort is limited in number, this is the first evidence of the existence of an altered bacterial microbiota in CAC clearly different from the one in SC patients.